Shanghai Junshi Biosciences to Review Financial Results
Company Announcements

Shanghai Junshi Biosciences to Review Financial Results

Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.

Shanghai Junshi Biosciences Co., Ltd. has scheduled a board meeting on October 29, 2024, to review and approve the company’s unaudited financial results for the first nine months of the year. Investors in the financial markets will be keen to see these results, as they provide insights into the company’s performance and future prospects.

For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App